Creating new methods for chemical synthesis using gold catalysts
Developing Asymmetric Gold Redox Catalysis for Challenging Chemical Transformations
This study is exploring new ways to use gold in making complex chemicals that could help create better medicines, aiming to improve how we develop new drugs that might benefit patients in the future.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-10848402 on NIH RePORTER |
What this research studies
This research focuses on developing innovative organic synthesis techniques that utilize gold catalysts to create complex chemical structures relevant to biochemistry and medicine. The project aims to overcome existing challenges in gold catalysis, particularly in asymmetric transformations and the synthesis of difficult-to-access compounds. By employing advanced methods such as strong oxidants and photoactivation, the researchers hope to enhance the efficiency of chemical synthesis processes that could lead to improved drug development and production. Patients may benefit indirectly through advancements in the creation of new medications and therapies.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals who require new or improved medications for various health conditions.
Not a fit: Patients with conditions that are not addressed by new chemical compounds or those who do not require pharmaceutical interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient production of important pharmaceuticals, ultimately improving patient access to new treatments.
How similar studies have performed: Previous research in gold catalysis has shown promise, indicating that this approach could lead to significant advancements in chemical synthesis.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Shi, Xiaodong — Univ of Maryland, College Park
- Study coordinator: Shi, Xiaodong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.